Search Results - "Katashima, Masataka"

Refine Results
  1. 1

    Pharmacokinetics of Mirabegron, a β3 -Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects by Iitsuka, Hiromi, MS, van Gelderen, Marcel, PhD, Katashima, Masataka, PhD, Takusagawa, Shin, PhD, Sawamoto, Taiji, PhD

    Published in Clinical therapeutics (01-05-2015)
    “…Abstract Purpose The objective of these studies was to evaluate the pharmacokinetic profile, safety, and tolerability of mirabegron, a β3 -adrenoceptor agonist…”
    Get full text
    Journal Article
  2. 2

    Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects by Shibata, Tomohisa, Nomura, Yuki, Takada, Akitsugu, Ueno, Mai, Katashima, Masataka, Yazawa, Rie, Furihata, Kenichi

    Published in Clinical pharmacology in drug development (01-04-2019)
    “…Roxadustat is a hypoxia‐inducible factor prolyl hydroxylase inhibitor in late‐stage clinical development for the treatment of anemia in chronic kidney disease…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females by Nomura, Yuki, Iitsuka, Hiromi, Toyoshima, Junko, Kuroishi, Kentaro, Hatta, Toshifumi, Kaibara, Atsunori, Katashima, Masataka, Moy, Selina, Sawamoto, Taiji

    Published in Drug metabolism and pharmacokinetics (01-12-2016)
    “…Mirabegron, the first selective β3-adrenoceptor agonist for the treatment of overactive bladder (OAB), inhibits cytochrome P450 isozyme CYP2D6. This study was…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies by Kusawake, Tomohiro, Keirns, James J., Kowalski, Donna, den Adel, Martin, Groenendaal-van de Meent, Dorien, Takada, Akitsugu, Ohtsu, Yoshiaki, Katashima, Masataka

    Published in Advances in therapy (01-12-2017)
    “…Introduction Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella–zoster virus infections. In this article…”
    Get full text
    Journal Article
  5. 5

    A phase I, open-label, single-dose micro tracer mass balance study of 14C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry by Miyatake, Daisuke, Nakada, Naoyuki, Takada, Akitsugu, Kato, Kota, Taniuchi, Yuta, Katashima, Masataka, Sawamoto, Taiji

    Published in Drug metabolism and pharmacokinetics (01-04-2018)
    “…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
    Get full text
    Journal Article
  6. 6

    A phase I, open-label, single-dose micro tracer mass balance study of 14 C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry by Miyatake, Daisuke, Nakada, Naoyuki, Takada, Akitsugu, Kato, Kota, Taniuchi, Yuta, Katashima, Masataka, Sawamoto, Taiji

    Published in Drug metabolism and pharmacokinetics (01-04-2018)
    “…ASP7991 is a calcimimetic that acts on the calcium-sensing receptor on parathyroid cell membranes and suppresses parathyroid hormone (PTH) secretion in the…”
    Get full text
    Journal Article
  7. 7

    Integrative pharmacokinetic–pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes by Takada, Akitsugu, Katashima, Masataka, Kaibara, Atsunori, Chono, Koji, Katsumata, Kiyomitsu, Sawamoto, Taiji, Suzuki, Hiroshi, Yano, Yoshitaka

    Published in Drug metabolism and pharmacokinetics (01-08-2016)
    “…Amenamevir is a novel drug that targets the viral helicase–primase complex. While dose-dependent efficacy had been observed in non-clinical studies, no clear…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections by Tabata, Kenji, Katashima, Masataka, Kawamura, Akio, Tanigawara, Yusuke, Sunagawa, Keisuke

    Published in Biological & pharmaceutical bulletin (01-08-2006)
    “…The objective of this study was to propose the appropriate dosage regimen of micafungin for pediatric use, considering the effects of dose-linearity, age and…”
    Get full text
    Journal Article
  10. 10

    Role of micafungin in the antifungal armamentarium by Ikeda, Fumiaki, Tanaka, Shigeki, Ohki, Hidenori, Matsumoto, Satoru, Maki, Katsuyuki, Katashima, Masataka, Barrett, David, Aoki, Yoshiyasu

    Published in Current medicinal chemistry (01-05-2007)
    “…Serious infections caused by opportunistic molds remain a major problem for public health. Immune deficiency following organ transplantation and aggressive…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections by Tabata, Kenji, Katashima, Masataka, Kawamura, Akio, Kaibara, Atsunori, Tanigawara, Yusuke

    Published in Drug metabolism and pharmacokinetics (01-01-2006)
    “…The object of this analysis was to develop a population pharmacokinetic model of micafungin, a new anti-fungal agent of the echinocandin class, to optimize…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression by Fukushi, Risa, Nomura, Yuki, Katashima, Masataka, Komatsu, Kanji, Sato, Yuichiro, Takada, Akitsugu

    Published in Clinical therapeutics (01-06-2020)
    “…The objectives of this study were to explore covariates of plasma quetiapine concentrations after oral administration of quetiapine extended-release…”
    Get full text
    Journal Article
  16. 16

    Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder by Fukushi, Risa, Nomura, Yuki, Katashima, Masataka, Komatsu, Kanji, Sato, Yuichiro, Takada, Akitsugu

    Published in Clinical therapeutics (01-08-2020)
    “…Quetiapine has been reported to prolong the QT interval, and has been used as a positive control in thorough QT studies. The objective of the present study was…”
    Get full text
    Journal Article
  17. 17

    Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males by Nakajo, Ikumi, Inoue, Hiroshi, Inaba, Masaki, Oikawa, Keishi, Katashima, Masataka, Sawamoto, Taiji, Kurumatani, Hajimu, Shiramoto, Masanari

    Published in Clinical drug investigation (01-06-2021)
    “…Background and Objectives Beraprost sodium (BPS), an orally administrable prostaglandin I 2 derivative, is used for the treatment of chronic arterial occlusion…”
    Get full text
    Journal Article
  18. 18

    Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function by Miyatake, Daisuke, Shibata, Tomohisa, Shibata, Mai, Kaneko, Yuichiro, Oda, Kazuo, Nishimura, Tetsuya, Katashima, Masataka, Sekino, Hisakuni, Furihata, Kenichi, Urae, Akinori

    Published in Clinical drug investigation (01-02-2020)
    “…Background and Objective This study measured and compared the exposure and safety of peficitinib (ASP015K), a novel oral Janus kinase inhibitor, in subjects…”
    Get full text
    Journal Article
  19. 19

    Analytical method validation for biomarkers as a drug development tool: points to consider by Ohtsu, Yoshiaki, Tanaka, Seiji, Igarashi, Harue, Kakehi, Masaaki, Mori, Tamiki, Nakamura, Takahiro, Ohashi, Rui, Shimizu, Hiroyuki, Yasuda, Yutaka, Okayama, Takashige, Kakuo, Hiroyuki, Yokoi, Hiroyuki, Horiuchi, Mizuki, Katashima, Masataka, Nakamura, Ryosuke, Saito, Kosuke, Saito, Yoshiro

    Published in Bioanalysis (01-09-2021)
    “…Biomarkers are an important drug developmental tool. Assessment of quantitative analytical methods of biomarkers is not included in any regulatory documents in…”
    Get full text
    Journal Article
  20. 20

    Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections by Kenji TABATAa, Masataka KATASHIMAb, Akio KAWAMURAc, Yusuke TANIGAWARAd, Keisuke SUNAGAWAe

    “…The objective of this study was to propose the appropriate dosage regimen of micafungin for pediatric use, considering the effects of dose-linearity, age and…”
    Get full text
    Journal Article